Cytomegalovirus (CMV) retinitis in AIDS: ganciclovir implant in comparison to systemic therapyGanciclovir-Implantat im Vergleich zur systemischen Therapie

被引:0
|
作者
Anne V. Fuchs
Eva Wolf
Andreas Scheider
Hans Jäger
Anselm Kampik
机构
[1] Augenklinik,
[2] Klinikum Innenstadt,undefined
[3] Ludwig-Maximilians-Universität München,undefined
[4] KIS,undefined
[5] Kuratorium für Immunschwäche,undefined
[6] München,undefined
来源
Der Ophthalmologe | 1999年 / 96卷
关键词
Key words Sustained-release ganciclovir • Cytomegalovirus retinitis • AIDS • Ganciclovir implant • Ganciclovir intraocular device; Schlüsselwörter Zytomegalievirus-Retinitis • Lokaltherapie • AIDS • Ganciclovirimplantat • Ganciclovirpellet;
D O I
暂无
中图分类号
学科分类号
摘要
Introduction: Untreated CMV retinitis with AIDS leads to blindness; therefore, a life-long virostatic treatment is required. It can either be administered systemically or locally, as there are different advantages and disadvantages. When treating patients we aim at therapy that preserves vision without diminishing quality of life. It should induce as few drug-induced side effects as possible and not shorten the patient's life expectation.
引用
收藏
页码:11 / 15
页数:4
相关论文
共 2 条
  • [1] Cytomegalovirus (CMV) retinitis in AIDS:: ganciclovir implant in comparison to systemic therapy
    Fuchs, AV
    Wolf, E
    Scheider, A
    Jäger, H
    Kampik, A
    OPHTHALMOLOGE, 1999, 96 (01): : 11 - 15
  • [2] Zur urogenitalen Klinik der lokalisierten/systemischen BCGitisRetrospektive Untersuchungen im direkten Vergleich zu Mitomycin CDevelopment and treatment of localized/systemic BCGitisRetrospective studies in direct comparison to mitomycin C
    W.‑D. U. Böhm
    R. Koch
    S. Wenzel
    M. P. Wirth
    M. Toma
    Der Urologe, 2018, 57 (5): : 568 - 576